About Saisei Pharma
About Saisei Pharma, a bio venture company
Founded in 2014 on the campus of Tokushima University's Faculty of Engineering, Saisei Pharma is a pioneering biotech venture dedicated to immune health and longevity. We are the developers, researchers, and manufacturers of the world’s first immune-supporting natural health food series - the MAF Series - which includes MAF Capsules, MAF Spray, M-Lollies, and M-Powder.
Our products are available through our official online store, serving both domestic and international customers.
Now headquartered in Osaka, our MAF products are manufactured at our Moriguchi Factory (Certification No. 26518), recognized by the Japan Health and Nutrition Food Association.
As a proud member of the Saisei Mirai Group, we collaborate closely with Saisei Mirai Medical Corporation clinics to drive research and development aimed at supporting a wide range of conditions - including acute and chronic infections, cancer, autism, chronic fatigue syndrome, multiple sclerosis, rheumatoid arthritis, Alzheimer’s disease, and dementia.
Saisei Pharma's Activities
As a bio venture company, we aim to develop products that are beneficial to your health.
The world's first healthy natural food, MAF series
This is the world’s first health-supporting natural food developed using a unique extraction method. Made from carefully selected natural ingredients, this easy-to-use anti-aging supplement is ideal for anyone looking to stay healthy, vibrant, and full of energy.
Approved as a food and supplement in various countries around the world
Regulatory Approvals
- Approved as a food: Japan, Sweden
- Approved as a supplement: United States, Lithuania, Ukraine
Patents acquired and being obtained in various countries around the world
Granted Patents
• Japan – Granted on September 14, 2018 (Patent No. 6401712)
• United States – Granted on June 18, 2019 (Patent No. US10322147B2)
Patent Applications Pending
• Europe
• Eastern Europe
• Australia
• Israel
• And many other countries
volunteer
[2019] Free provision of samples for pilot studies ・Kazakhstan: Multiple sclerosis, autism ・Chile: Autism
[2018] Free sample provision for pilot study: Australia: Autism
[2016] Free provision of samples for pilot study: Indonesia, autism
Regenerative Future Group
We collaborate with five domestic clinics under the Medical Corporation Saiseishin, as well as with venture companies, pharmacies, universities, and medical institutions in Japan and abroad. Together, we are committed to delivering cutting-edge medical care with sincerity and integrity.
